Cargando…
Structured serological testing is an essential component to investigating SARS-CoV-2 reinfection
Autores principales: | Pallett, Scott J C, Jones, Rachael, Randell, Paul, Davies, Gary W, Moore, Luke S P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817473/ https://www.ncbi.nlm.nih.gov/pubmed/33484647 http://dx.doi.org/10.1016/S1473-3099(20)30990-7 |
Ejemplares similares
-
Optimising the initial investigation of suspected cases of SARS-CoV-2 reinfection
por: Pallett, Scott JC., et al.
Publicado: (2021) -
Serological assays for delayed SARS-CoV-2 case identification – Author's reply
por: Pallett, Scott J C, et al.
Publicado: (2020) -
Caution required with use of ritonavir-boosted PF-07321332 in COVID-19 management
por: Heskin, Joseph, et al.
Publicado: (2022) -
Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants
por: Pallett, Scott J C, et al.
Publicado: (2022) -
Characterising differential antibody response is integral to future SARS-CoV-2 serostudies
por: Pallett, Scott John Charles, et al.
Publicado: (2020)